RecruitingNCT06345521
Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
A Comprehensive Research of Pediatric Heart Failure-- Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
Sponsor
China National Center for Cardiovascular Diseases
Enrollment
100 participants
Start Date
Jan 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Establish a follow-up management system for pediatric heart failure and a registration platform for end-stage heart failure
Eligibility
Max Age: 14 Years
Inclusion Criteria2
- Patients younger than 14 years of age
- refractory heart failure
Exclusion Criteria1
- \-
Interventions
OTHERNo intervention
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06345521
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations